APA aipamena

Tarantelli, C., Zhang, L., Curti, E., Gaudio, E., Spriano, F., Priebe, V., . . . Bertoni, F. (2019). The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents. Haematologica.

Chicago Style aipamena

Tarantelli, Chiara, et al. "The Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) Demonstrated Synergies With Other Anti-lymphoma Targeted Agents." Haematologica 2019.

MLA aipamena

Tarantelli, Chiara, et al. "The Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) Demonstrated Synergies With Other Anti-lymphoma Targeted Agents." Haematologica 2019.